New advancement of the IMO Foundation for the treatment of retinal diseases without cureThe entity's team of researchers generates 3 new cell lines with specific mutations in genes involved in retinal dystrophies, currently without treatment.Fundación IMO researchers have managed to take the retinal dystrophies research project one step further by registering three new cell lines. Specifically, the research team, led by Dr. Esther Pomares and located in the IMO Molecular Biology Laboratory, has managed to develop 3 new stem cell models from patients affected by the following three diseases: achromatopsia, the disease of Best and Retinitis pigmentosa.Altogether, the 7 stem cell lines obtained by the Fundación IMO team are unique models in the world since they present particular mutations in 6 genes involved in retinal dystrophies: 1 related to Stargardt disease, 3 related to Retinitis Pigmentosa, 1 with Best's disease and 1 with achromatopsia.